Multiple Sclerosis Medical Animation

Marijuana Helps Relieve MS Pain
Researchers from the University of California, San Diego School of Medicine have found that smoking marijuana can help relieve pain, and muscle tightness "spasticity" in individuals with multiple sclerosis (MS). The study is published in the Canadian Medical Association Journal (CMAJ)...

Marijuana May Relieve Multiple Sclerosis Symptoms
The advocates of proposition 19, the bill that tried to legalize cannabis in California, must be turning cartwheels at the news coming out of University of California, San Diego School of Medicine...

Some Symptoms Of Multiple Sclerosis Respond To Smoked Cannabis
A clinical study of 30 adult patients with multiple sclerosis (MS) at the University of California, San Diego School of Medicine has shown that smoked cannabis may be an effective treatment for spasticity - a common and disabling symptom of this neurological disease...

FDA Issues Warning On Unproven MS Treatment
FDA has issued an alert to healthcare professionals and those suffering from multiple sclerosis. An avante garde procedure used to treat suffers of chronic cerebrospinal venous insufficiency (CCSVI), has been deemed unsafe, causing potential injury and even death...

More Than 95 Percent Of Surveyed Multiple Sclerosis Specialists Have Seen Misdiagnosed Patients In Last Year
It is relatively common for doctors to diagnose someone with multiple sclerosis when the patient doesn't have the disease - a misdiagnosis that not only causes patients potential harm but costs the U.S. health care system untold millions of dollars a year, according to a study published online in the journal Neurology...

In Mouse Model, Halting An Enzyme Can Slow Multiple Sclerosis
Researchers studying multiple sclerosis (MS) have long been looking for the specific molecules in the body that cause lesions in myelin, the fatty, insulating cells that sheathe the nerves...

Gilenya Heart Side Effects - European Medicine Agency Gives New Recommendations
After a review of the latest evidence of Gilenya's safety aspects, the EMA (European Medicines Agency) recommends that healthcare professionals reduce the risk of heart problems, in association with the multiple sclerosis medicine Gilenya (fingolimod), by not prescribing the drug to patients with a history of cardiovascular and cerebrovascular disease or those who take heart-...

Significant Improvement In Disability Scores With Alemtuzumab
Genzyme presented additional data at the 64th Annual Meeting of the American Academy of Neurology from its Phase II CARE-MS II trial, which demonstrated that the Expanded Disability Status Scale (EDSS), i.e...

Potential Treatment For Cerebral Palsy, Other Neurologic Disorders With Nano-Devices That Cross Blood-Brain Barrier
A team of scientists from Johns Hopkins and elsewhere have developed nano-devices that successfully cross the blood-Brain barrier and deliver a drug that tames brain-damaging inflammation in rabbits with cerebral palsy...

Gilenya Successfully Treated Relapsing MS Patients For Up To 7 Years
At the 64th annual meeting of the American Academy of Neurology (AAN), Novartis will present new data that supports Gilenya's (fingolimod) efficacy and safety profile and introduce new data of its investigational compound BAF312 (siponimod), a selective modulator of the S1P receptor subtypes 1 and 5 (S1P1, -5R modulator) in its multiple sclerosis portfolio3...

MS Drug Gilenya Positive Benefit-Risk Profile Following CHMP Review, Europe
According to Novartis, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has confirmed a positive benefit-risk profile for their once-a-day orally administered drug Gilenya (fingolimod). In agreement with the CHMP, the company has updated their E.U...

MS Therapy Gilenya (Fingolimod) Updated Prescribing Data In USA
Novartis says it has updated prescribing data for multiple sclerosis therapy Gilenya (Fingolimod) after a review by the Food and Drug Administration (FDA). The prescribing information includes new parameters for selecting patients, based on specific cardiovascular considerations...

Do Omega-3 Fatty Acids Help MS? Apparently Not
About 2.5 million people worldwide suffer from multiple sclerosis (MS), a chronic, incurable disease of the central nervous system. Some MS sufferers take or have tried omega-3 fatty acid supplements to control the disease, because the essential fatty acids are believed to have anti-inflammatory and neuro-protective effects in multiple sclerosis...

Mitigating Symptoms, Improving Quality Of Life Of Multiple Sclerosis Patients
Researchers report that performing angioplasty (a treatment that involves temporarily inserting and blowing up a tiny balloon inside a clogged artery to help widen it) on veins in the neck and chest is safe - and may be an effective way to treat the venous abnormalities found in those with multiple sclerosis and provide symptom relief...

'Significant' Symptom Relief Reported In MS Patients By Interventional Radiologists
Short-term follow-up supports evidence that angioplasty of azygos and jugular veins safe, improves quality of life for those with multiple sclerosis, say researchers at Society of Interventional Radiology's 37th Annual Scientific Meeting Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blo...